1,128 results on '"Tursi, Antonio"'
Search Results
152. Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide
153. What is the best long-term treatment?
154. Onset of Ulcerative Colitis Under Treatment With Adalimumab
155. Remediation of polluted waters by means of surface modified natural cellulose fibers
156. Role of Inflammation in the Pathogenesis of Diverticular Disease
157. THREE-HOUR HYDROGEN BREATH TEST FOR ASSESSING LACTOSE MALABSORPTION IN CLINICAL PRACTICE: TO GIVE 50 OR 20 GRAMS OF LACTOSE?
158. Factors influencing lactose intolerance
159. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal
160. Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
161. Endoscopic Diagnosis of Diverticulosis and Diagnosis of Symptomatic Uncomplicated Diverticular Disease of the Colon: If You Properly Classify, You Properly Make the Diagnosis
162. A review on biomass: importance, chemistry, classification, and conversion
163. Gitelman syndrome triggered by proton-pump inhibitor use
164. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease
165. Sa1204 – A Comparison of Different Treatments for Symptomatic Reflux Esophagitis: A Real-Life Study
166. Sa1729 – Risk Factors for Colonic Diverticulosis: A Study in Primary Care Setting
167. Sa1728 – The Prognostic Value of a New Endoscopic Classification for Diverticular Disease: Dica (Diverticular Inflammation and Complication Assessment)
168. Su1954 – Long-Term Efficacy of Rifaximin to Manage the Symptomatic Uncomplicated Diverticular Disease of the Colon
169. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon
170. “Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease: Reply”
171. The “DICA” Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists
172. Diverticulosis today
173. Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
174. Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy
175. Rifaximin for the Management of Colonic Diverticular Disease: far Beyond a Simple Antibiotic
176. Symptomatic Uncomplicated Diverticular Disease: Chronic Abdominal Pain in Diverticulosis Is Not Enough to Make the Diagnosis
177. Detection of HCV RNA in gastric mucosa—associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma
178. Endoscopic findings and clinical patterns are not useful for distinguishing low from high grade gastric MALT lymphoma
179. Urinary metabolic profiling and symptomatic uncomplicated diverticular disease of the colon
180. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study.
181. Il net-attivismo e la ridefinizione della democrazia
182. Net-Activism and Redefining Democracy
183. Sa1729 – Risk Factors for Colonic Diverticulosis: A Study in Primary Care Setting
184. Effectiveness of golimumab in inducing remission and clinical response in outpatient ulcerative colitis
185. Diet in colonic diverticulosis: is it useful?
186. International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease.
187. Removal of Endocrine Disrupting Chemicals from Water: Adsorption of Bisphenol-A by Biobased Hydrophobic Functionalized Cellulose
188. Mesalazine to Treat Symptomatic Uncomplicated Diverticular Disease and to Prevent Acute Diverticulitis Occurrence. A Systematic Review with Meta-Analysis of Randomized, Placebo-Controlled Trials
189. Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis
190. 2D/3D switchable displays through PDLC reverse mode parallax barrier
191. Efficacy and safety of a new nutraceutical formulation in managing patients with symptomatic uncomplicated diverticular disease: a 12-month, prospective, pilot study
192. A critical appraisal of advances in the diagnosis of diverticular disease
193. Remediation of hydrocarbons polluted water by hydrophobic functionalized cellulose
194. 50 - Reflux Esophagitis after Helicobacter Pylori Eradication: The Role of Gastric Acid Secretion
195. Tu1315 - Is the Interval Between the first and the Second H.P. Eradication Therapy Relevant for the Success of the Cure? A Comparison Between One Week, One Month and One Year
196. Tu1640 - The Clinical Outcome of Sudd: A 15-Years Prospective Study
197. Mo1194 - Natural History of Gastric Ulcer in a 25 Years Follow-Up: Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drugs
198. Tu1237 - Epidemiology of Diverticular Disease of the Colon: A Preliminary Analysis from the International “Dica” Prospective Study
199. Tu1311 - Effectiveness and Safety of Pylera ® in Patients Infected by Helicobacter Pylori : A Large, Prospective, Real Life Study
200. The Pathophysiology of Colonic Diverticulosis: Inflammation versus Constipation?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.